Acute myocardial infarction (AMI) continues to be a leading cause of death worldwide, necessitating rapid and accurate diagnosis to mitigate severe cardiac damage. The electrocardiogram (ECG) remains ...
Findings from the Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS) registry ...
This retrospective, single‐center study included all patients aged 18 to 65 years who presented with ACS and underwent ...
McSweeney and colleagues surveyed 515 women who were diagnosed as having an acute myocardial infarction (AMI). [1] The women ranged from 54 to 78 years of age, 95% were white, and 95% had prodromal ...
The authors collected resource utilization and cost of treatment data (in US dollars, excluding physicians' fees) from the cost accounting systems of two Canadian hospitals (n=215) and seven US ...
Deepak Bhatt, MD, Mount Sinai Heart, highlights the kidney-specific outcomes of the pivotal EMPACT-MI clinical trial in an interview at the 2024 European Society of Cardiology Congress. At the 2024 ...
Cardiovascular imaging, particularly in the setting of acute myocardial infarction (AMI), has advanced rapidly in recent years, with growing attention to ...
A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...
In a recent study published in JAMA, researchers investigated whether Tongxinluo, a Chinese medicinal compound, could improve clinical outcomes among ST-segment elevation myocardial infarction (STEMI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results